Funding
← Back to your selection

UPMC Enterprises

Activity from announced rounds

Activity in this selectionOct 22, 2026 · AI · Jan 1, 2026

UPMC Enterprises is the organization identified in its own RAAPID, BrainCheck and ai3Bio materials.

Recorded funding activity

RAAPID supplies healthcare risk-adjustment software. Ai3Bio develops immune-cell-targeted medicines. The pending ai3Bio relation stays in draft, and the organization remains separate from UPMC and the University of Pittsburgh.

Sources
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
2
First participation on record · 1 follow-on
Funding in participating rounds
$13M
1 disclosed · full round size, not this investor’s share

By stage

Series A2
Undisclosed1

By primary sector

Healthtech3

By country

United States3

Rounds

3 in this selection
RAAPID

Provides AI-powered risk adjustment solutions for healthcare

UndisclosedStrategic
Role not disclosed
RAAPID

Provides AI-powered risk adjustment solutions for healthcare

UndisclosedSeries A+
Role not disclosed
BrainCheck

Provides digital cognitive assessment and care for healthcare organizations

$13MSeries A
Role not disclosed